Having peripheral artery disease increases the chance of having a heart attack.
Lilly’s fibromyalgia-fighting drug, Cymbalta (duloxetine)—its second-best seller after Zyprexa—is anything but normal.
Even as new reports surface about fake medical articles Pfizer planted to sell seizure drug Neurontin for unapproved uses.
A new study shows that a red wine pill provides more health benefits than drinking hundreds of glasses of the “sweet nectar of the gods.”
In a recent study, the effects of chondroitin sulphate on osteoarthritis of the knee were assessed.
Reports of undisclosed financial ties between researchers and drugmakers have eroded public confidence.
Newer “atypical” drugs for schizophrenia and other mental problems may in fact carry a greater risk of a fatal heart attack than older medicines.
In 1994, Dr. Whorwell coauthored an article in the Lancet that made the case that insoluble fiber is more likely to cause harm than do good in IBS patients.